Performance of 2019 ESC risk classification and the Steno type 1 risk engine in predicting cardiovascular events in adults with type 1 diabetes: A retrospective study

被引:4
|
作者
Tecce, Nicola [1 ]
Masulli, Maria [1 ]
Palmisano, Luisa [1 ]
Gianfrancesco, Salvatore [1 ]
Piccolo, Roberto [1 ]
Pacella, Daniela [2 ]
Bozzetto, Lutgarda [1 ]
Massimino, Elena [1 ]
Della Pepa, Giuseppe [1 ]
Lupoli, Roberta [3 ]
Vaccaro, Olga [1 ]
Riccardi, Gabriele [1 ]
Capaldo, Brunella [1 ]
机构
[1] Univ Naples Federico II, Dept Clin Med & Surg, Via S Pansini 5, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy
[3] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy
关键词
Type; 1; diabetes; Cardiovascular disease; STENO Type 1 risk engine; 2019 ESC guidelines; DISEASE; MORTALITY; 1ST;
D O I
10.1016/j.diabres.2022.110001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: The study compares the performance of the European Society of Cardiology (ESC) risk criteria and the Steno Type 1 Risk Engine (ST1RE) in the prediction of cardiovascular (CV) events. Methods: 456 adults with type 1 diabetes (T1D) were retrospectively studied. During 8.5 +/- 5.5 years of observation, twenty-four patients (5.2%) experienced a CV event. The predictive performance of the two risk models was evaluated by classical metrics and the event-free survival analysis. Results: The ESC criteria show excellent sensitivity (91.7%) and suboptimal specificity (64.4 %) in predicting CV events in the very high CV risk group, but a poor performance in the high/moderate risk groups. The ST1RE algorithm shows a good predictive performance in all CV risk categories. Using ESC classification, the event-free survival analysis shows a significantly higher event rate in the very high CV risk group compared to the high/moderate risk group (p < 0.0019). Using the ST1RE algorithm, a significant difference in the event-free survival curve was found between the three CV risk categories (p < 0.0001). Conclusions: In T1D the ESC classification has a good performance in predicting CV events only in those at very high CV risk, whereas the ST1RE algorithm has a good performance in all risk categories.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Carotid preclinical atherosclerosis in Mediterranean individuals with type 1 diabetes: prevalence and association with the Steno T1 Risk Engine
    Amor, A. J.
    Ortega, E.
    Perea, V.
    Gimenez, M.
    Vinagre, I.
    Esmatjes, E.
    Conget, I.
    DIABETOLOGIA, 2017, 60 : S515 - S515
  • [32] Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and renal disease as assessed by Steno Risk Engines in adults with type 1 diabetes
    Stougaard, E. B.
    Rossing, P.
    Vistisen, D.
    Banks, P.
    Girard, M.
    Davies, M. J.
    Persson, F.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S47 - S47
  • [33] Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, Reduces the Risk of Cardiovascular and Renal Disease as Assessed by Steno Risk Engines in Adults With Type 1 Diabetes
    Stougaard, Elisabeth B.
    Rossing, Peter
    Vistisen, Dorte
    Banks, Phillip
    Girard, Manon
    Davies, Michael J.
    Persson, Frederik
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 674 - 675
  • [34] Risk Models for the Development of Cardiovascular and Microvascular Events in Adults with Type 2 Diabetes in the FIELD Study
    Ong, Kwok Leung
    O'Connell, Rachel L.
    Januszewski, Andrzej S.
    Donoghoe, Mark W.
    Gebski, Val
    Sullivan, David
    Rye, Kerry Ann
    Scott, Russell S.
    Best, James D.
    Taskinen, Marja-Riitta
    Simes, Robert J.
    Jenkins, Alicia
    Keech, Anthony C.
    DIABETES, 2023, 72
  • [35] Risk Factors for Cardiovascular Disease in Type 1 Diabetes
    Nathan, David M.
    Bebu, Ionut
    Braffett, Barbara H.
    Lachin, John M.
    Orchard, Trevor J.
    Cowie, Catherine C.
    Lopes-Virella, Maria
    Schutta, Mark
    DIABETES, 2016, 65 (05) : 1370 - 1379
  • [36] Cardiovascular disease risk prediction in type 1 diabetes
    Farran, B.
    McGurnaghan, S.
    Blackbourn, L.
    McKeigue, P. M.
    Colhoun, H. M.
    DIABETOLOGIA, 2017, 60 : S532 - S533
  • [37] Cardiovascular disease risk in type 1 diabetes Reply
    Huxley, Rachel R.
    Peters, Sanne A. E.
    Mishra, Gita D.
    Woodward, Mark
    Lancet Diabetes & Endocrinology, 2015, 3 (05): : 317 - 317
  • [38] Cardiovascular risk perceptibn in patients with type 1 diabetes
    Hansen, MM
    Young, DA
    Hoff, HK
    Liu, HP
    DIABETES, 2004, 53 : A223 - A224
  • [39] Menopause and Cardiovascular Risk in Women with Type 1 Diabetes
    Keshawarz, Amena
    Duca, Lindsey M.
    Shah, Viral N.
    Pyle, Laura
    Sippl, Rachel M.
    Snell-Bergeon, Janet K.
    DIABETES, 2016, 65 : A122 - A122
  • [40] Type 1 diabetes, metabolic syndrome and cardiovascular risk
    Chillaron, Juan J.
    Flores Le-Roux, Juana A.
    Benaiges, David
    Pedro-Botet, Juan
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (02): : 181 - 187